Breast cancer has remained one of the most frequent and life-threatening cancers in females globally, putting emphasis on better diagnostics in its early stages to solve the problem of therapy effectiveness and survival. This work enhances the assessment of breast cancer by employing progressive residual networks (PRN) and ResNet-50 within the framework of Progressive Residual Multi-Class Support Vector Machine-Net. Built on concepts of deep learning, this creative integration optimizes feature extraction and raises the bar for classification effectiveness, earning an almost perfect 99.63% on our tests. These findings indicate that PRMS-Net can serve as an efficient and reliable diagnostic tool for early breast cancer detection, aiding radiologists in improving diagnostic accuracy and reducing false positives. The separation of the data into different segments is possible to determine the architecture's reliability using the fivefold cross-validation approach. The total variability of precision, recall, and F1 scores clearly depicted in the box plot also endorse the competency of the model for marking proper sensitivity and specificity-highly required for combating false positive and false negative cases in real clinical practice. The evaluation of error distribution strengthens the model's rationale by giving validation of practical application in medical contexts of image processing. The high levels of feature extraction sensitivity together with highly sophisticated classification methods make PRMS-Net a powerful tool that can be used in improving the early detection of breast cancer and subsequent patient prognosis.

Nuclear medicine is rapidly evolving with new molecular imaging targets and advanced computational tools that promise to enhance diagnostic precision and personalized therapy. Recent years have seen a surge in novel PET and SPECT tracers, such as those targeting prostate-specific membrane antigen (PSMA) in prostate cancer, fibroblast activation protein (FAP) in tumor stroma, and tau protein in neurodegenerative disease. These tracers enable more specific visualization of disease processes compared to traditional agents, fitting into a broader shift toward precision imaging in oncology and neurology. In parallel, artificial intelligence (AI) and machine learning techniques are being integrated into tracer development and image analysis. AI-driven methods can accelerate radiopharmaceutical discovery, optimize pharmacokinetic properties, and assist in interpreting complex imaging datasets. This editorial provides an expanded overview of emerging imaging targets and techniques, including theranostic applications that pair diagnosis with radionuclide therapy, and examines how AI is augmenting nuclear medicine. We discuss the implications of these advancements within the field's historical trajectory and address the regulatory, manufacturing, and clinical challenges that must be navigated. Innovations in molecular targeting and AI are poised to transform nuclear medicine practice, enabling more personalized diagnostics and radiotheranostic strategies in the era of precision healthcare.

While several artificial intelligence (AI)-assisted medical imaging applications are reported in the recent orthopaedic literature, comparison of the clinical efficacy and utility of these applications is currently lacking. The aim of this systematic review is to evaluate the effectiveness and reliability of AI applications in orthopaedic imaging, focusing on their impact on diagnostic accuracy, image segmentation and operational efficiency across various imaging modalities. Based on the PRISMA guidelines, a comprehensive literature search of PubMed, Cochrane and Scopus databases was performed, using combinations of keywords and MeSH descriptors ('AI', 'ML', 'deep learning', 'orthopaedic surgery' and 'imaging') from inception to March 2024. Included were studies published between September 2018 and February 2024, which evaluated machine learning (ML) model effectiveness in improving orthopaedic imaging. Studies with insufficient data regarding the output variable used to assess the reliability of the ML model, those applying deterministic algorithms, unrelated topics, protocol studies, and other systematic reviews were excluded from the final synthesis. The Joanna Briggs Institute (JBI) Critical Appraisal tool and the Risk Of Bias In Non-randomised Studies-of Interventions (ROBINS-I) tool were applied for the assessment of bias among the included studies. The 53 included studies reported the use of 11.990.643 images from several diagnostic instruments. A total of 39 studies reported details in terms of the Dice Similarity Coefficient (DSC), while both accuracy and sensitivity were documented across 15 studies. Precision was reported by 14, specificity by nine, and the F1 score by four of the included studies. Three studies applied the area under the curve (AUC) method to evaluate ML model performance. Among the studies included in the final synthesis, Convolutional Neural Networks (CNN) emerged as the most frequently applied category of ML models, present in 17 studies (32%). The systematic review highlights the diverse application of AI in orthopaedic imaging, demonstrating the capability of various machine learning models in accurately segmenting and analysing orthopaedic images. The results indicate that AI models achieve high performance metrics across different imaging modalities. However, the current body of literature lacks comprehensive statistical analysis and randomized controlled trials, underscoring the need for further research to validate these findings in clinical settings. Systematic Review; Level of evidence IV.

This narrative review outlines the current applications and considerations of artificial intelligence (AI) for diagnosis, management, and prognosis in rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), and psoriatic arthritis (PsA). Advances in AI, mainly in machine learning and deep learning, have significantly influenced medical research and clinical practice over the past decades by offering precisions in data understanding and treatment approaches. AI applications have enhanced risk prediction models, early diagnosis, and better management in RA. Predictive models have guided treatment decisions such as-response to methotrexate and biologics-while wearable devices and electronic health records (EHR) improve disease activity monitoring. In addition, AI applications are reported as promising for the early identification of extra-articular involvements, prediction, detection, and assessment of comorbidities. In axSpA, AI-driven models using imaging techniques such as sacroiliac radiography, magnetic resonance imaging, and computed tomography have increased diagnostic accuracy, especially for early inflammatory changes. Predictive algorithms help stratify and predict disease outcomes, while clinical decision support systems integrate clinical and imaging data for optimized management. For PsA, AI has also allowed for early detection among psoriasis patients using genetic markers, immune profiling, and EHR-based natural language processing systems. Overall, AI models may predict diagnosis, disease severity, treatment response, and comorbidities to improve care in patients with RA, axSpA, and PsA. As a rapidly developing and improving area, AI has the potential to change our current perspective of medical practice by offering better diagnostic evaluation and treatments and improved patient follow-up. Multimodal AI, focusing on collaboration, reliability, transparency, and patient-centered innovation, looks like the future of medical practice. However, data quality, model interpretability, and ethical considerations must be addressed to ensure reliable and equitable applications in clinical practice.

Advancements in medical imaging technology have facilitated the acquisition of high-quality brain images through computed tomography (CT) or magnetic resonance imaging (MRI), enabling professional brain specialists to diagnose brain tumors more effectively. However, manual diagnosis is time-consuming, which has led to the growing importance of automatic detection and classification through brain imaging. Conventional object detection models for brain tumor detection face limitations in brain tumor detection owing to the significant differences between medical images and natural scene images, as well as challenges such as complex backgrounds, noise interference, and blurred boundaries between cancerous and normal tissues. This study investigates the application of deep learning to brain tumor detection, analyzing the effect of three factors, the number of model parameters, input data batch size, and the use of anchor boxes, on detection performance. Experimental results reveal that an excessive number of model parameters or the use of anchor boxes may reduce detection accuracy. However, increasing the number of brain tumor samples improves detection performance. This study, introduces a backbone network built using RepConv and RepC3, along with FGConcat feature map splicing module to optimize the brain tumor detection model. The experimental results show that the proposed RepConv-RepC3-FGConcat Network (RRFNet) can learn underlying semantic information about brain tumors during training stage, while maintaining a low number of parameters during inference, which improves the speed of brain tumor detection. Compared with YOLOv8, RRFNet achieved a higher accuracy in brain tumor detection, with a mAP value of 79.2%. This optimized approach enhances both accuracy and efficiency, which is essential in clinical settings where time and precision are critical.

Cervical spine disorders are becoming increasingly common, particularly among sedentary populations. The accurate segmentation of cervical vertebrae is critical for diagnostic and research applications. Traditional segmentation methods are limited in terms of precision and applicability across imaging modalities. The aim of this study is to develop and evaluate a fully automatic segmentation method and a user-friendly tool for detecting cervical vertebral body using a combined neural network model based on the YOLOv11 and U-Net3 + models. A dataset of X-ray and magnetic resonance imaging (MRI) images was collected, enhanced, and annotated to include 2136 X-ray images and 2184 MRI images. The proposed YOLO-UNet ensemble model was trained and compared with four other groups of image extraction models, including YOLOv11, DeepLabV3+, U-Net3 + for direct image segmentation, and the YOLO-DeepLab network. The evaluation metrics included the Dice coefficient, Hausdorff distance, intersection over union, positive predictive value, and sensitivity. The YOLO-UNet model combined the advantages of the YOLO and U-Net models and demonstrated excellent vertebral body segmentation capabilities on both X-ray and MRI datasets, which were closer to the ground truth images. Compared with other models, it achieved greater accuracy and a more accurate depiction of the vertebral body shape, demonstrated better versatility, and exhibited superior performance across all evaluation indicators. The YOLO-UNet network model provided a robust and versatile solution for cervical vertebral body segmentation, demonstrating excellent accuracy and adaptability across imaging modalities on both X-ray and MRI datasets. The accompanying user-friendly tool enhanced usability, making it accessible to both clinical and research users. In this study, the challenge of large-scale medical annotation tasks was addressed, thereby reducing project costs and supporting advancements in medical information technology and clinical research.

Medical image segmentation plays an important role in medical diagnosis and treatment. Most recent medical image segmentation methods are based on a convolutional neural network (CNN) or Transformer model. However, CNN-based methods are limited by locality, whereas Transformer-based methods are constrained by the quadratic complexity of attention computations. Alternatively, the state-space model-based Mamba architecture has garnered widespread attention owing to its linear computational complexity for global modeling. However, Mamba and its variants are still limited in their ability to extract local receptive field features. To address this limitation, we propose a novel residual spatial state-space (RSSS) block that enhances spatial feature extraction by integrating global and local representations. The RSSS block combines the Mamba module for capturing global dependencies with a receptive field attention convolution (RFAC) module to extract location-sensitive local patterns. Furthermore, we introduce a residual adjust strategy to dynamically fuse global and local information, improving spatial expressiveness. Based on the RSSS block, we design a U-shaped SA-UMamba segmentation framework that effectively captures multi-scale spatial context across different stages. Experiments conducted on the Synapse, ISIC17, ISIC18 and CVC-ClinicDB datasets validate the segmentation performance of our proposed SA-UMamba framework.